This retrospective chart review study addresses these gaps by evaluating the application of anti-CGRP therapies in adolescents with chronic migraine (CM), chronic daily headache (CDH), new daily persistent headache (NDPH), and chronic post-traumatic headache (PTH). The gene discussed is CALCA; the disease is cutaneous mastocytosis.